whole-genome sequencing
Ovation.io Collecting WGS, Clinical Data From 8,500 Patients on GLP-1 Meds
The firm said it struck a three-year licensing deal with a top pharmaceutical company that will use the data to advance GLP-1 receptor agonist research.
Myriad Genetics, MD Anderson Partner to Study Clinical Utility of MRD Assay
Under the five-year agreement, the partners will assess the clinical utility of Myriad's Precise MRD test in breast, gastrointestinal, genitourinary, and gynecological cancers.
Researchers Test Single-Cell Whole-Genome Sequencing to Select Therapy in Relapsed Multiple Myeloma
Premium
At ASH's annual meeting, a study showed the potential for this method to inform the next treatment after patients relapse on BCMA- or GPRC5D-targeted therapy.
NGS Tumor Testing Gaps Persist in Metastatic Prostate, Urothelial Cancers
A retrospective health record analysis revealed an inconsistent rise in rates of next-generation sequencing testing in metastatic prostate cancer and advanced urothelial cancer.
GenieUs Genomics Aims to Stratify ALS Patients Using Bioinformatics Platform, Long-Read Sequencing
Premium
The Australian firm seeks to validate its DiGAP platform in a clinical study by categorizing ALS patients according to their most affected biological pathways.